Modus Therapeutics Holding AB (publ) (STO:MODTX)

Market Cap	37.70M -26.6%
Revenue (ttm)	n/a
Net Income	-17.94M
EPS	-0.44
Shares Out	121.63M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	136,205
Average Volume	309,018
Open	0.3130
Previous Close	0.3100
Day's Range	0.2970 - 0.3410
52-Week Range	0.2650 - 5.0000
Beta	0.23
RSI	46.15
Earnings Date	Feb 25, 2026

About STO:MODTX

Modus Therapeutics Holding AB (publ), a biotechnology company, develops a treatment for sepsis and septic shock in Sweden. It develops Sevuparin, a lipopolysaccharide in Phase IIa trial to treat patients with sepsis, septic shock, anemia associated with chronic kidney disease, endotoxemia, severe malaria, and other diseases involving severe systemic inflammation. Modus Therapeutics Holding AB (publ) was founded in 2011 and is headquartered in Stockholm, Sweden.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2011
• Employees: 2
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MODTX